| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/23/2001 | US20010016191 Viewing informatoin, selecting a site for, and preparing a molecule of an alteration on a granulocyte colony-stimulating factor (g-csf) three dimensional molecule, and testing for desired characteristics; retain internal core helices |
| 08/23/2001 | DE10004468A1 Allenoxidcyclasegen und dessen Verwendung zum Herstellen von Jasmonsäure Allenoxidcyclasegen and its use for the production of jasmonic acid |
| 08/23/2001 | CA2398861A1 Gene disruption methodologies for drug target discovery |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/22/2001 | EP1126027A1 Cell death inhibition by the caspase-12 activation inhibitor MAGE-3 |
| 08/22/2001 | EP1125135A2 A complex of a chaperone with -amyloid and methods employing this complex |
| 08/22/2001 | EP1124966A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 08/22/2001 | EP1124965A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124961A2 Thrombopoietic compounds |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
| 08/22/2001 | EP1124849A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124846A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 08/22/2001 | EP1124577A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 08/22/2001 | EP1124570A2 Novel neuropilin/growth factor binding and uses thereof |
| 08/22/2001 | EP1124568A1 Polyspecific binding molecules and uses thereof |
| 08/22/2001 | EP0550645B1 Surface expression libraries of heteromeric receptors |
| 08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
| 08/21/2001 | US6277975 Fusions of P-selectin ligand protein and polynucleotides encoding same |
| 08/21/2001 | US6277959 Isolated mammalian membrane protein genes; related reagents |
| 08/21/2001 | US6277821 For treating gramnegative and mycobacterium infections; endotoxin and heparin neutralization |
| 08/21/2001 | US6277631 Recombinant yeast (schizosaccharomyces pombe or saccharomyces cerevisiae) expression vectors |
| 08/21/2001 | US6277600 Trimeric chimera protein and collagen matrix containing chimera protein |
| 08/21/2001 | US6277599 Monoclonal antiboby for the preferential killing of tumors; for diagnosis of cancer; for the treatment of cancer |
| 08/21/2001 | US6277564 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 08/16/2001 | WO2001059459A2 Compositions and methods for screening therapeutic agents |
| 08/16/2001 | WO2001059133A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059112A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/16/2001 | WO2001058957A2 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/16/2001 | WO2001058951A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/16/2001 | WO2001058949A2 Heterologous polypeptide of the tnf family |
| 08/16/2001 | WO2001058916A2 Antibodies to ccr5 |
| 08/16/2001 | WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/16/2001 | WO2000046367A3 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/16/2001 | WO2000006739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/16/2001 | US20010014474 Preparing hybridoma cell line which produces antibody which specifically recognizes and binds to cell surface antigen associated with a neoplastic human cell; diagnosis, therapy |
| 08/16/2001 | US20010014328 A multispecific binding molecule, comprising a first binding determinant which binds an Fc alpha receptor is not blocked by human immunoglobin A and a second binding determinant binds target cancer cell antigen |
| 08/16/2001 | US20010014327 Conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody and expression in mammal cells to produce the conjugated antibody; enhanced immune response |
| 08/16/2001 | US20010014325 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 08/16/2001 | EP1144627A3 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/16/2001 | EP1123405A1 Materials and methods involving conditional aggregation domains |
| 08/16/2001 | EP1123398A2 Molecular pathogenicide mediated plant disease resistance |
| 08/16/2001 | EP1123393A1 Follistatin-related protein zfsta2 |
| 08/16/2001 | EP1123389A1 A method of affinity separation and ligands for use therein |
| 08/16/2001 | EP1123315A1 Multiple domain glycoprotein hormones and methods of using |
| 08/16/2001 | EP1123114A1 Virus-like particles for the induction of autoantibodies |
| 08/16/2001 | EP0759944B1 Target cell binding chimaeric peptides |
| 08/16/2001 | EP0749444B1 Hybrid human/animal factor viii |
| 08/16/2001 | CA2400802A1 Compositions and methods for screening therapeutic agents |
| 08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
| 08/16/2001 | CA2399945A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2368681A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/15/2001 | CN1308674A Multivalent T cell receptor complexes |
| 08/15/2001 | CN1308671A Myelin basic protein peptides and uses thereof |
| 08/15/2001 | CN1308638A Fabric care compositions comprising cellulose binding domains |
| 08/15/2001 | CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 08/14/2001 | US6274721 Toxins active against pests |
| 08/14/2001 | US6274556 Administering polypeptide derivative to treat inflammatory bowel disease and to prevent leukocyte infiltration into tissues |
| 08/14/2001 | US6274348 Methods for the preparation of positively charged proteins |
| 08/14/2001 | US6274338 Human c-Maf compositions and methods of use thereof |
| 08/14/2001 | US6274117 Cytokines that bind the cell surface receptor Hek |
| 08/14/2001 | CA2185155C Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 08/14/2001 | CA1341285C Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
| 08/10/2001 | CA2331876A1 Water-soluble ligand-binding proteins and analogs of ligand-gated channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/09/2001 | WO2001057242A2 Methods of protein destabilization and uses thereof |
| 08/09/2001 | WO2001057224A2 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 08/09/2001 | WO2001057216A2 Method for the production of a protein |
| 08/09/2001 | WO2001057183A2 Method for producing circular or multimeric protein species in vivo or in vitro and related methods |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057068A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/09/2001 | WO2001057065A2 Combinatorial protein domains |
| 08/09/2001 | WO2001021796A3 Gl50 molecules and uses therefor |
| 08/09/2001 | WO2000037643A3 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/09/2001 | CA2400013A1 Methods of protein destabilization and uses thereof |
| 08/09/2001 | CA2399809A1 Combinatorial protein domains |
| 08/09/2001 | CA2399644A1 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399026A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/08/2001 | EP1122314A1 Method for the production of a protein |
| 08/08/2001 | EP1121448A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 08/08/2001 | EP1121437A2 Metastatic breast and colon cancer regulated genes |
| 08/08/2001 | EP1121383A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 08/08/2001 | EP1121382A2 Interferon-beta fusion proteins and uses |
| 08/08/2001 | EP1121381A2 Zinc finger binding domains for gnn |
| 08/08/2001 | EP1121156A2 Polymer conjugates of interferon beta- 1a and their uses |
| 08/08/2001 | CN1307633A Laundry detergent and/or fabric care composition comprising modified enzyme |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271362 Nucleotide sequences coding a immunoglobulin; for use as a tool for genetic engineering |
| 08/07/2001 | US6271348 Fusion protein which inhibits transcription in eukaryotic cells; for use as a tool in gene regulation |
| 08/07/2001 | US6271341 Fusion protein associated with the control of gene expression; for use as a tool in controlled gene expression |
| 08/07/2001 | US6271197 Administering a geranylgeranyl transferase inhibitor |
| 08/07/2001 | US6271014 A polypeptide with proteolytic activity; therapy for periodontal disease, rheumatoid arthritis, aging, cancer, wound healing, bone resorption, pregnancy and parturition |
| 08/07/2001 | US6270969 Recombinational cloning using engineered recombination sites |
| 08/07/2001 | US6270765 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 08/02/2001 | WO2001055393A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001055211A2 Fil-1 theta dnas and polypeptides |
| 08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |